111 related articles for article (PubMed ID: 8385653)
1. Effect of PGE2 on thymocyte proliferation induced by Con A or IL-4 + PMA.
Daculsi R; Vaillier D; Bezian JH; Gualde N
Int J Immunopharmacol; 1993 Feb; 15(2):195-204. PubMed ID: 8385653
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway.
Borger P; Kauffman HF; Postma DS; Vellenga E
Blood; 1996 Jan; 87(2):691-8. PubMed ID: 8555492
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activated T cells display increased sensitivity to PGE2.
Sunder-Plassmann R; Majdic O; Knapp W; Holter W
Cell Immunol; 1991 Dec; 138(2):289-99. PubMed ID: 1657408
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal.
Borger P; Vellenga E; Gringhuis SI; Timmerman JA; Lummen C; Postma DS; Kauffman HF
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):231-40. PubMed ID: 9500757
[TBL] [Abstract][Full Text] [Related]
5. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E
Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331
[TBL] [Abstract][Full Text] [Related]
6. IL-2, IL-6, and IFN-gamma have distinct effects on the IL-4 plus PMA-induced proliferation of thymocyte subpopulations.
Hodgkin PD; Cupp J; Zlotnik A; Howard M
Cell Immunol; 1990 Mar; 126(1):57-68. PubMed ID: 2105854
[TBL] [Abstract][Full Text] [Related]
7. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
[TBL] [Abstract][Full Text] [Related]
8. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway.
Shin HC; Benbernou N; Esnault S; Guenounou M
Cytokine; 1999 Apr; 11(4):257-66. PubMed ID: 10328864
[TBL] [Abstract][Full Text] [Related]
9. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
10. Effect of PGE2 on the cell surface molecule expression in PMA treated thymocytes.
Daculsi R; Vaillier D; Carron JC; Gualde N
Immunol Lett; 1998 Feb; 60(2-3):81-8. PubMed ID: 9557948
[TBL] [Abstract][Full Text] [Related]
11. Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine production.
Watanabe S; Yssel H; Harada Y; Arai K
Int Immunol; 1994 Apr; 6(4):523-32. PubMed ID: 8018594
[TBL] [Abstract][Full Text] [Related]
12. Linomide enhances apoptosis in CD4+CD8+ thymocytes.
Harring AC; Xu Z; Andersson G; Hedlund G
Scand J Immunol; 1997 Nov; 46(5):488-94. PubMed ID: 9393631
[TBL] [Abstract][Full Text] [Related]
13. Calcium signaling restitution prevents T-cell proliferative suppression by prostaglandin E2.
Choudhry MA; Sayeed MM
Shock; 1996 Aug; 6(2):101-5. PubMed ID: 8856843
[TBL] [Abstract][Full Text] [Related]
14. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
15. Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation.
Bartik MM; Brooks WH; Roszman TL
Cell Immunol; 1993 May; 148(2):408-21. PubMed ID: 8388322
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5.
Katamura K; Shintaku N; Yamauchi Y; Fukui T; Ohshima Y; Mayumi M; Furusho K
J Immunol; 1995 Nov; 155(10):4604-12. PubMed ID: 7594459
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
18. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M
Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.
Betz M; Fox BS
J Immunol; 1991 Jan; 146(1):108-13. PubMed ID: 1845802
[TBL] [Abstract][Full Text] [Related]
20. The sensitivity of IL-4 production for cAMP inducers is lost in CD4+ T cells from aged mice.
Dobber R; van den Bergh P; Tielemans M; Schuitemaker J; Nagelkerken L
Int Immunol; 1993 Sep; 5(9):1167-76. PubMed ID: 7902131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
